"Novavax's strength is that it has the second-grea

"Novavax's strength is that it has the second-greatest capacity among the current leaders -- which also include Moderna, Pfizer, AstraZeneca, and Johnson & Johnson. Novavax is ramping up to produce 2 billion doses annually by the middle of this year. AstraZeneca's capacity is about 3 billion doses a year. Moderna plans on producing 500 million to 1 billion doses this year, while Johnson & Johnson aims to deliver 1 billion doses. Pfizer's coronavirus vaccine partner BioNTech recently said they may be able to produce 2 billion doses this year -- that's up from an earlier target of 1.3 billion doses."

These are the numbers that Cytodyn has to produce to meet this pandemic as well plus for all other indications. How is that going to happen? I don't know but what I do know is it won't happen very soon. Help would be great but will we get it?

What is the cost of production at quantities like these? All of these BPs probably manufacture in house most of their product. That would cut costs.

I would love to see the day that Leronlimab would flow like Southern Comfort and not cost much more!